Search filters
Launch of TerugBetaalRegeling Acecort® en Fludrace®Launch of TerugBetaalRegeling Acecort® en Fludrace®

Launch of TerugBetaalRegeling Acecort® en Fludrace®

01/06/2020

The health insurer does not fully reimburse Acecort® 1mg and Fludrace® 62.5mcg. The producer of this medicine has therefore asked...

Termination TerugBetaalRegeling Xarelto®

Termination TerugBetaalRegeling Xarelto®

24/12/2019

Xarelto® is fully reimbursement from the 1st of January 2020. For this reason the co-payment is ended. Expenses from before the...

Termination TerugBetaalRegeling Invega®

Termination TerugBetaalRegeling Invega®

02/12/2019

Invega® is fully reimbursement from the 1st of December 2019. For this reason the co-payment is ended. Expenses from before the...

Specified overview health insurer

Specified overview health insurer

28/11/2019

To consider and process an invoice of a GVS medicine, we need a specified overview of your healthcare costs issued by your health...

Termination TerugBetaalRegeling Fampyra®

Termination TerugBetaalRegeling Fampyra®

08/11/2019

Fampyra® is fully reimbursement from the 1st of September 2019. For this reason the co-payment for Fampyra ended per August 31,...

You are currently offline. Some pages or content may fail to load.